BillTrack50 logo
Free Signup Login
Bill

Bill > HB3350

IL HB3350

IL HB3350
PATIENT ACCESS 340B PHARMACY

summary

Introduced
02/07/2025
In Committee
03/21/2025
Crossed Over
Passed
Dead

Introduced Session

104th General Assembly

Bill Summary

Creates the Patient Access to Pharmacy Protection Act. Defines terms. Provides that no person, including a pharmaceutical manufacturer, may deny, restrict, prohibit, condition, or otherwise interfere with, either directly or indirectly, the acquisition of a 340B drug by, or delivery of a 340B drug to, a 340B covered entity or a 340B contract pharmacy authorized to receive 340B drugs on behalf of the 340B covered entity unless such receipt is prohibited by federal law. Provides that no person, including a pharmaceutical manufacturer, may impose any restriction on the ability of a 340B covered entity to contract with or designate a 340B contract pharmacy including restrictions relating to the number, location, ownership, or type of 340B contract pharmacy. Provides that no person, including a pharmaceutical manufacturer, may require or compel a 340B covered entity or 340B contract pharmacy to submit or otherwise provide ingredient cost or pricing data pertinent to 340B drugs unless required by State or federal law; institute requirements in any way relating to how a 340B covered entity manages its inventory of 340B drugs that are not required by a State or federal agency, including requirements relating to the frequency or scope of audits of inventory management systems of a 340B covered entity or a 340B contract pharmacy; or submit data or information that is not required by State or federal law as a condition for a 340B covered entity, its 340B contract pharmacy, or a location otherwise authorized by a 340B covered entity to receive 340B drugs. Sets forth provisions concerning enforcement of this Act; preemption of this Act; and severability of this Act. Effective immediately.

AI Summary

This bill creates the Patient Access to Pharmacy Protection Act, which aims to safeguard the 340B drug discount program in Illinois by preventing pharmaceutical manufacturers from interfering with drug acquisition and distribution. Specifically, the bill prohibits manufacturers from denying, restricting, or conditioning the acquisition or delivery of 340B drugs to covered entities or contract pharmacies, and bars manufacturers from imposing limitations on contract pharmacies' number, location, ownership, or type. The legislation also prevents manufacturers from requiring 340B covered entities or contract pharmacies to submit pricing data or inventory management information beyond what is legally mandated. The bill provides enforcement mechanisms allowing the Department of Financial and Professional Regulation and 340B covered entities to investigate violations and seek injunctions, monetary damages, and civil penalties up to $10,000 per violation. The law defines key terms such as 340B drugs (medications purchased at reduced prices by eligible healthcare organizations) and establishes that its protections are intended to preserve healthcare access, especially for rural and medically underserved communities. The bill ensures that any enforcement actions align with federal law and includes provisions for severability, meaning that if one part of the law is found invalid, the remaining provisions can still be applied.

Committee Categories

Budget and Finance

Sponsors (25)

Last Action

Added Co-Sponsor Rep. Elizabeth "Lisa" Hernandez (on 04/24/2025)

bill text

bill summary

Loading...

bill summary

Loading...
Loading...